✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Zhejiang Huahai Pharmaceutical Co Ltd

Common Name
Zhejiang Huahai Pharmaceutical
Country
China (Mainland)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
8,797
Ticker
600521
Exchange
Shanghai Stock Exchange
Description
Zhejiang Huahai Pharmaceutical Co., Ltd. is a prominent player in the global pharmaceutical industry, focusing on the research, development, and manufacturing of high-quality pharmaceutical products. ...

Zhejiang Huahai Pharmaceutical's GHG Emissions Data Preview

In 2024, Zhejiang Huahai Pharmaceutical completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Zhejiang Huahai Pharmaceutical has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2024
Total Scope 1
58,691a
Total Scope 2
Unspecified Calculation Method
349,692a
Total Scope 3
N/A
Total Scope 1 Revenue Intensity (tCO2e/$M)
44.8637a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=600521&reporting_period=2024"

Verified Sources Behind Zhejiang Huahai Pharmaceutical’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Zhejiang Huahai Pharmaceutical's CSR Report 2024
a. Zhejiang Huahai Pharmaceutical's CSR Report 2024

Insights into Zhejiang Huahai Pharmaceutical's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of Zhejiang Huahai Pharmaceutical amounted to 408,383 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Zhejiang Huahai Pharmaceutical's Scope 1 Emissions Over Time

2024015 k30 k45 k60 ktCO2e
  • Total Scope 1
  • Year-over-Year Change

What are Zhejiang Huahai Pharmaceutical's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Zhejiang Huahai Pharmaceutical were 58,691 metric tons of CO₂ equivalent (tCO₂e).a

What are Zhejiang Huahai Pharmaceutical's Scope 2 emissions?

In 2024, Zhejiang Huahai Pharmaceutical reported Scope 2 greenhouse gas (GHG) emissions of 349,692 tCO₂e without specifying the calculation method.a

What methodology does Zhejiang Huahai Pharmaceutical use for Scope 2 reporting?

In 2024, Zhejiang Huahai Pharmaceutical reported its Scope 2 emissions using an unspecified methodology.a

Zhejiang Huahai Pharmaceutical's Scope 2 Emissions Over Time

2024090 k180 k270 k360 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Zhejiang Huahai Pharmaceutical’s GHG Emissions Intensity Compared to Industry Peers

In 2024, Zhejiang Huahai Pharmaceutical reported Scope 1 greenhouse gas (GHG) emissions of 58,691 tCO₂e and total revenues of USD 1,308 millions. This translates into an emissions intensity of 44.86 tCO₂e per millions USD.a

Zhejiang Huahai Pharmaceutical's Scope 1 Emissions Intensity Compared to Peers

2002,00010,000100,0001,000,000Scope 1 Emissions (tCO2e)502001,0002,00010,000Revenues (Millions of USD)Yunnan Baiyao GroupYear: 2025Scope 1: 34,719 tCO2eRevenue: $M 5,883Scope 1 Intensity: 5.90 tCO2e/$MSichuan Biokin PharmaceuticalYear: 2025Scope 1: 8,090 tCO2eRevenue: $M 360Scope 1 Intensity: 22.48 tCO2e/$MHansoh Pharmaceutical GroupYear: 2025Scope 1: 11,834 tCO2eRevenue: $M 2,147Scope 1 Intensity: 5.51 tCO2e/$MJiangsu Hengrui PharmaceuticalsYear: 2025Scope 1: 54,874 tCO2eRevenue: $M 4,518Scope 1 Intensity: 12.15 tCO2e/$MCanSino BiologicsYear: 2025Scope 1: 2,121 tCO2eRevenue: $M 151Scope 1 Intensity: 14.02 tCO2e/$MBioKangtaiYear: 2025Scope 1: 15,001 tCO2eRevenue: $M 382Scope 1 Intensity: 39.29 tCO2e/$MJoincareYear: 2025Scope 1: 219,583 tCO2eRevenue: $M 2,173Scope 1 Intensity: 101.03 tCO2e/$MChengdu Kanghong Pharmaceutical GroupYear: 2025Scope 1: 11,555 tCO2eRevenue: $M 655Scope 1 Intensity: 17.64 tCO2e/$MBetta PharmaceuticalsYear: 2025Scope 1: 1,268 tCO2eRevenue: $M 516Scope 1 Intensity: 2.46 tCO2e/$MWalvax BiotechnologyYear: 2024Scope 1: 7,643 tCO2eRevenue: $M 387Scope 1 Intensity: 19.77 tCO2e/$MDizal PharmaceuticalYear: 2025Scope 1: 887 tCO2eRevenue: $M 114Scope 1 Intensity: 7.75 tCO2e/$MHumanwell Healthcare (Group)Year: 2025Scope 1: 24,083 tCO2eRevenue: $M 3,423Scope 1 Intensity: 7.04 tCO2e/$MLuye Pharma GroupYear: 2023Scope 1: 10,755 tCO2eRevenue: $M 864Scope 1 Intensity: 12.44 tCO2e/$MDong-E-E-JiaoYear: 2024Scope 1: 20,046 tCO2eRevenue: $M 811Scope 1 Intensity: 24.71 tCO2e/$MShenzhen Salubris PharmaceuticalsYear: 2024Scope 1: 11,399 tCO2eRevenue: $M 550Scope 1 Intensity: 20.73 tCO2e/$MZhejiang Jiuzhou PharmaceuticalYear: 2025Scope 1: 57,658 tCO2eRevenue: $M 787Scope 1 Intensity: 73.28 tCO2e/$MHepalinkYear: 2025Scope 1: 13,483 tCO2eRevenue: $M 777Scope 1 Intensity: 17.36 tCO2e/$MCR Double-CraneYear: 2024Scope 1: 58,155 tCO2eRevenue: $M 1,536Scope 1 Intensity: 37.86 tCO2e/$MTasly Pharmaceutical GroupYear: 2024Scope 1: 37,370 tCO2eRevenue: $M 1,164Scope 1 Intensity: 32.09 tCO2e/$MApeloa PharmaceuticalYear: 2025Scope 1: 75,760 tCO2eRevenue: $M 1,397Scope 1 Intensity: 54.21 tCO2e/$MLivzon Pharmaceutical GroupYear: 2025Scope 1: 175,562 tCO2eRevenue: $M 1,717Scope 1 Intensity: 102.25 tCO2e/$MChangchun High-TechYear: 2025Scope 1: 133,335 tCO2eRevenue: $M 1,726Scope 1 Intensity: 77.25 tCO2e/$MSimcere Pharmaceutical GroupYear: 2025Scope 1: 5,428 tCO2eRevenue: $M 1,104Scope 1 Intensity: 4.92 tCO2e/$MDa Ren TangYear: 2025Scope 1: 3,870 tCO2eRevenue: $M 702Scope 1 Intensity: 5.51 tCO2e/$MZhejiang Huahai PharmaceuticalYear: 2024Scope 1: 58,691 tCO2eRevenue: $M 1,308Scope 1 Intensity: 44.86 tCO2e/$M

How does Zhejiang Huahai Pharmaceutical's GHG emissions intensity compare to its peers?

In 2024, Zhejiang Huahai Pharmaceutical reported a Scope 1 emissions intensity of 44.86 tCO₂e per millions USD. Compared to the peer group median of 18.71, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a

Where does Zhejiang Huahai Pharmaceutical rank on GHG emissions intensity within its industry?

In 2024, Zhejiang Huahai Pharmaceutical ranked 20 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a

This places Zhejiang Huahai Pharmaceutical among the least efficient performers, with one of the highest emissions intensities in its sector.a

Want Full Access to Zhejiang Huahai Pharmaceutical's GHG Emissions Dataset?
Start 30-Day Free Trial